oxazoles has been researched along with Cardiomyopathy, Congestive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, C; Kim, SJ; Liu, J; Molina, CA; Odashima, M; Sadoshima, J; Soler, S; Thaisz, J; Vatner, DE; Vatner, SF; Yamamoto, S; Yang, G; Yatani, A; Yehia, G; Zablocki, D | 1 |
1 other study(ies) available for oxazoles and Cardiomyopathy, Congestive
Article | Year |
---|---|
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.
Topics: Alkaloids; Animals; Apoptosis; Benzophenanthridines; Cardiomegaly; Cardiomyopathy, Dilated; Caspase 3; Caspases; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Genes, Dominant; Heart Ventricles; Marine Toxins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Organ Specificity; Oxazoles; Phenanthridines; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Transduction, Genetic | 2003 |